Your browser doesn't support javascript.
Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Verbruggen, Lisanne C; Wang, Yuehan; Armenian, Saro H; Ehrhardt, Matthew J; van der Pal, Helena J H; van Dalen, Elvira C; van As, Jorrit W; Bardi, Edit; Baust, Katja; Berger, Claire; Castagnola, Elio; Devine, Katie A; Gebauer, Judith; Marchak, Jordan Gilleland; Glaser, Adam W; Groll, Andreas H; Haeusler, Gabrielle M; den Hartogh, Jaap; Haupt, Riccardo; Hjorth, Lars; Kato, Miho; Kepák, Tomás; Koopman, Maria M W Rianne; Langer, Thorsten; Maeda, Miho; Michel, Gisela; Muraca, Monica; Nathan, Paul C; van den Oever, Selina R; Pavasovic, Vesna; Sato, Satomi; Schulte, Fiona; Sung, Lillian; Tissing, Wim; Uyttebroeck, Anne; Mulder, Renée L; Kuehni, Claudia; Skinner, Roderick; Hudson, Melissa M; Kremer, Leontien C M.
  • Verbruggen LC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Wang Y; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Armenian SH; Department of Population Sciences, City of Hope National Medical Center, Duarte, California, USA.
  • Ehrhardt MJ; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • van der Pal HJH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • van As JW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Bardi E; Cochrane Childhood Cancer, Amsterdam, the Netherlands.
  • Baust K; St Anna Childrens Hospital, Vienna, Austria.
  • Berger C; Kepler University Clinic, Med Campus IV, Linz, Austria.
  • Castagnola E; Department for Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Devine KA; Department for Pediatric Hematology and Oncology CHU Nord, University Hospital Saint-Etienne, Saint-Priest en Jarez, France.
  • Gebauer J; Epidemiology of Childhood and Adolescent Cancers, CRESS, INSERM, UMR 1153, Paris Descartes University, Villejuif, France.
  • Marchak JG; Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Glaser AW; Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, New Jersey, USA.
  • Groll AH; Institute for Endocrinology and Diabetes, University of Luebeck, Ratzeburger Allee 160, Luebeck, 23562, Germany.
  • Haeusler GM; Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA.
  • den Hartogh J; Department of Paediatric Oncology, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK.
  • Haupt R; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University Children's Hospital, Münster, Germany.
  • Hjorth L; NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Kato M; Department of Infectious Diseases, Peter MacCallum Cancer Centre and Royal Children's Hospital, Parkville, Victoria, Australia.
  • Kepák T; Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Koopman MMWR; Dutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, the Netherlands.
  • Langer T; Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Maeda M; Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden.
  • Michel G; Department of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Okinawa, Japan.
  • Muraca M; University Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University, Brno, Czech Republic.
  • Nathan PC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • van den Oever SR; University Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Ratzeburger Allee 160, Luebeck, 23562, Germany.
  • Pavasovic V; Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
  • Sato S; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
  • Schulte F; Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini, Genova, Italy.
  • Sung L; The Hospital for Sick Children, Toronto, Canada.
  • Tissing W; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Uyttebroeck A; Department of Malignant Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
  • Mulder RL; St. Luke's International University, Tokyo, Japan.
  • Kuehni C; Department of Oncology, Division of Psychosocial Oncology, University of Calgary, Calgary, AB, Canada.
  • Skinner R; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
  • Hudson MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Kremer LCM; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Pediatr Blood Cancer ; 67(12): e28702, 2020 12.
Article in English | MEDLINE | ID: covidwho-793756
ABSTRACT
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Cancer Survivors / Neoplasms Type of study: Experimental Studies / Observational study / Prognostic study Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Young adult Language: English Journal: Pediatr Blood Cancer Journal subject: Hematology / Neoplasms / Pediatrics Year: 2020 Document Type: Article Affiliation country: Pbc.28702

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Cancer Survivors / Neoplasms Type of study: Experimental Studies / Observational study / Prognostic study Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Young adult Language: English Journal: Pediatr Blood Cancer Journal subject: Hematology / Neoplasms / Pediatrics Year: 2020 Document Type: Article Affiliation country: Pbc.28702